Genetic Research

Recent Studies

  • A team at the Dana-Farber Cancer Institute have found new gene mutations that cause estrogen receptor-positive (ER+) breast cancers to become resistant to standard therapies and metastasize. Identifying these new targets could lead to new therapies for those facing ER+ metastatic breast cancer. To learn more about this research update, click here.
  •  A new research study from Biomed Central explores male BRCA mutation carriers: clinical characteristics and cancer spectrum. This is one of the largest studies describing the cancer characteristics of male BRCA mutation carriers. To read more, click here. 

Comments are closed.